- Home
- CNET vs APVO Comparison
CNET vs APVO Comparison
Compare CNET & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- APVO
- Stock Information
- Founded
- CNET 2003
- APVO 2016
- Country
- CNET China
- APVO United States
- Employees
- CNET N/A
- APVO N/A
- Industry
- CNET Advertising
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- CNET Consumer Discretionary
- APVO Health Care
- Exchange
- CNET Nasdaq
- APVO Nasdaq
- Market Cap
- CNET 2.8M
- APVO 3.3M
- IPO Year
- CNET N/A
- APVO N/A
- Fundamental
- Price
- CNET $1.58
- APVO $0.67
- Analyst Decision
- CNET
- APVO Strong Buy
- Analyst Count
- CNET 0
- APVO 1
- Target Price
- CNET N/A
- APVO $296.00
- AVG Volume (30 Days)
- CNET 16.7K
- APVO 8.7M
- Earning Date
- CNET 04-15-2025
- APVO 05-07-2025
- Dividend Yield
- CNET N/A
- APVO N/A
- EPS Growth
- CNET N/A
- APVO N/A
- EPS
- CNET N/A
- APVO N/A
- Revenue
- CNET $15,439,000.00
- APVO N/A
- Revenue This Year
- CNET N/A
- APVO N/A
- Revenue Next Year
- CNET N/A
- APVO N/A
- P/E Ratio
- CNET N/A
- APVO N/A
- Revenue Growth
- CNET N/A
- APVO N/A
- 52 Week Low
- CNET $1.35
- APVO $0.60
- 52 Week High
- CNET $4.53
- APVO $51.06
- Technical
- Relative Strength Index (RSI)
- CNET 55.07
- APVO 30.74
- Support Level
- CNET $1.53
- APVO $0.60
- Resistance Level
- CNET $1.61
- APVO $0.80
- Average True Range (ATR)
- CNET 0.06
- APVO 0.19
- MACD
- CNET 0.01
- APVO 0.03
- Stochastic Oscillator
- CNET 80.00
- APVO 6.97
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as the related data and technical services to small and medium enterprises in the PRC. It offers a variety channels of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of ecommerce O2O advertising and marketing services and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.